KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Dividends payables (2016 - 2025)

Historic Dividends payables for Pfizer (PFE) over the last 17 years, with Q2 2025 value amounting to $2.4 billion.

  • Pfizer's Dividends payables rose 273.11% to $2.4 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $2.4 billion, marking a year-over-year increase of 273.11%. This contributed to the annual value of $2.4 billion for FY2024, which is 274.03% up from last year.
  • Per Pfizer's latest filing, its Dividends payables stood at $2.4 billion for Q2 2025, which was up 273.11% from $2.4 billion recorded in Q4 2024.
  • In the past 5 years, Pfizer's Dividends payables ranged from a high of $2.4 billion in Q2 2025 and a low of $2.2 billion during Q3 2021
  • For the 5-year period, Pfizer's Dividends payables averaged around $2.3 billion, with its median value being $2.3 billion (2022).
  • Per our database at Business Quant, Pfizer's Dividends payables skyrocketed by 402.41% in 2021 and then surged by 240.11% in 2022.
  • Quarter analysis of 5 years shows Pfizer's Dividends payables stood at $2.2 billion in 2021, then grew by 2.4% to $2.3 billion in 2022, then increased by 3.0% to $2.4 billion in 2023, then rose by 2.74% to $2.4 billion in 2024, then grew by 0.33% to $2.4 billion in 2025.
  • Its Dividends payables stands at $2.4 billion for Q2 2025, versus $2.4 billion for Q4 2024 and $2.4 billion for Q2 2024.